Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pavía-López, Abel A
154  Ergebnisse:
Artikel (Online) X
Personensuche X
?
1

Guía mexicana de práctica clínica para el diagnóstico y el ..:

Pavía-López, Abel A. ; Magaña-Serrano, José A. ; Cigarroa-López, José A....
Archivos de Cardiología de México.  94 (2024)  91 - p. , 2024
Link: https://doi.org/10.24875..
 
?
2

Guía de práctica clínica mexicana para el diagnóstico y tra..:

Pavía-López, Abel A. ; Alcocer-Gamba, Marco A. ; Ruiz-Gastélum, Edith D....
Archivos de Cardiología de México.  92 (2022)  91 - p. , 2022
Link: https://doi.org/10.24875..
 
?
3

Risk stratification and lipid evaluation in mexican patient..:

De los Ríos-Ibarra, Manuel Odín ; Leiva-Pons, José Luis ; Rodríguez-Reyes, Humberto...
Atherosclerosis Plus.  50 (2022)  - p. 32-39 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Safety and tolerability of β-blockers: importance of cardio..:

Marti, Hans-Peter ; Pavía López, Abel Alberto ; Schwartzmann, Pedro
Current Medical Research and Opinion.  40 (2024)  sup1 - p. 55-62 , 2024
Link: https://doi.org/10.1080/..
 
?
5

Real-World Insights into Evolocumab Use in Patients with Hy..:

Gupta, Milan ; Wani, Rajvi J. ; Al Faraidy, Khalid...
Cardiology and Therapy.  12 (2023)  4 - p. 703-722 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Outcomes and effect of somatic mutations after erythropoies..:

Caballero, Juan Carlos ; Dávila, Julio ; López-Pavía, María...
Therapeutic Advances in Hematology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
7

Outcomes after intensive chemotherapy for secondary and mye..:

Martínez-Cuadrón, David ; Megías-Vericat, Juan E. ; Gil, Cristina...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
8

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute M..:

Labrador, Jorge ; Martínez-Cuadrón, David ; de la Fuente, Adolfo...
Cancers.  14 (2022)  9 - p. 2342 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Acute leukemia arising from myeloproliferative or myelodysp..:

Hernández-Boluda, Juan-Carlos ; Martínez-Cuadrón, David ; Pereira, Arturo...
Leukemia Research.  115 (2022)  - p. 106821 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Treatment patterns and outcomes of 2310 patients with secon..:

Martínez-Cuadrón, David ; Megías-Vericat, Juan E. ; Serrano, Josefina...
Blood Advances.  6 (2022)  4 - p. 1278-1295 , 2022
Link: https://doi.org/10.1182/..
 
?
11

Therapy-related myelodysplastic syndromes deserve specific ..:

Kuendgen, A. ; Nomdedeu, M. ; Tuechler, H....
Leukemia.  35 (2020)  3 - p. 835-849 , 2020
Link: https://doi.org/10.1038/..
 
?
12

Analysis of SNP Array Abnormalities in Patients with DE NOV..:

Ibáñez, Mariam ; Such, Esperanza ; Onecha, Esther...
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
13

Evolving treatment patterns and outcomes in older patients ..:

Martínez-Cuadrón, David ; Serrano, Josefina ; Gil, Cristina...
Leukemia.  35 (2020)  6 - p. 1571-1585 , 2020
Link: https://doi.org/10.1038/..
 
?
14

The modular network structure of the mutational landscape o..:

Ibáñez, Mariam ; Carbonell-Caballero, José ; Such, Esperanza...
PLOS ONE.  13 (2018)  10 - p. e0202926 , 2018
Link: https://doi.org/10.1371/..
 
?
15

Prognostic impact of gene mutations in myelodysplastic synd..:

Martín, Iván ; Such, Esperanza ; Navarro, Blanca...
Blood Cancer Journal.  7 (2017)  12 - p. , 2017
Link: https://doi.org/10.1038/..
 
1-15